Xu T - Search Results

1

A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data.

Wu B, Hu Q, Tian F, Wu F, Li Y, Xu T. Wu B, et al. Among authors: xu t. Sci Rep. 2021 May 21;11(1):10709. doi: 10.1038/s41598-021-90108-7. Sci Rep. 2021. PMID: 34021217 Free PMC article.

2

Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.

Wu B, Li D, Xu T, Luo M, He Z, Li Y. Wu B, et al. Among authors: xu t. Sci Rep. 2021 Feb 11;11(1):3690. doi: 10.1038/s41598-021-83099-y. Sci Rep. 2021. PMID: 33574396 Free PMC article.

3

Chen C, Wu B, Zhang C, Xu T. Chen C, et al. Among authors: xu t. Int Immunopharmacol. 2021 Jun;95:107498. doi: 10.1016/j.intimp.2021.107498. Epub 2021 Mar 13. Int Immunopharmacol. 2021. PMID: 33725634

4

Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system.

Chen C, Zhang C, Jin Z, Wu B, Xu T. Chen C, et al. Among authors: xu t. Int J Clin Pharm. 2022 Jun;44(3):689-697. doi: 10.1007/s11096-022-01395-7. Epub 2022 Apr 21. Int J Clin Pharm. 2022. PMID: 35449347

5

Immune-related adverse events in older adults: Data mining of the FDA Adverse Event Reporting System.

Chen C, Zhang C, Wu B, Xu T. Chen C, et al. Among authors: xu t. J Geriatr Oncol. 2022 Sep;13(7):1017-1022. doi: 10.1016/j.jgo.2022.05.009. Epub 2022 Jun 1. J Geriatr Oncol. 2022. PMID: 35660091

6

Interventions for reducing inflammation in familial Mediterranean fever.

Yin X, Tian F, Wu B, Xu T. Yin X, et al. Among authors: xu t. Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD010893. doi: 10.1002/14651858.CD010893.pub4. Cochrane Database Syst Rev. 2022. PMID: 35349164 Free PMC article. Review.

7

Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System.

Wu B, Shen P, Yin X, Yu L, Wu F, Chen C, Li J, Xu T. Wu B, et al. Among authors: xu t. Br J Clin Pharmacol. 2023 Feb;89(2):440-448. doi: 10.1111/bcp.15336. Epub 2022 Apr 7. Br J Clin Pharmacol. 2023. PMID: 35349180 Free article.

8

Acute Kidney Injury Associated With Remdesivir: A Comprehensive Pharmacovigilance Analysis of COVID-19 Reports in FAERS.

Wu B, Luo M, Wu F, He Z, Li Y, Xu T. Wu B, et al. Among authors: xu t. Front Pharmacol. 2022 Mar 25;13:692828. doi: 10.3389/fphar.2022.692828. eCollection 2022. Front Pharmacol. 2022. PMID: 35401177 Free PMC article.

9

Interventions for reducing inflammation in familial Mediterranean fever.

Wu B, Xu T, Li Y, Yin X. Wu B, et al. Among authors: xu t. Cochrane Database Syst Rev. 2018 Oct 19;10(10):CD010893. doi: 10.1002/14651858.CD010893.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2022 Mar 29;3:CD010893. doi: 10.1002/14651858.CD010893.pub4 PMID: 30338514 Free PMC article. Updated.

10

Adverse events identified by the global trigger tool at a university hospital: A retrospective medical record review.

Hu Q, Wu B, Zhan M, Jia W, Huang Y, Xu T. Hu Q, et al. Among authors: xu t. J Evid Based Med. 2019 May;12(2):91-97. doi: 10.1111/jebm.12329. Epub 2018 Dec 3. J Evid Based Med. 2019. PMID: 30511516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,274 results

Search Page

Filters